ioncologi.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
User-agent:
Meta Tags
Title Immuno-Oncology Biotech |
Description About A biotechnology company specializing in
Keywords N/A
Server Information
WebSite ioncologi faviconioncologi.com
Host IP 198.71.232.3
Location United States
Related Websites
Site Rank
More to Explore
ioncologi.com Valuation
US$449,346
Last updated: 2023-05-08 23:46:04

ioncologi.com has Semrush global rank of 23,554,923. ioncologi.com has an estimated worth of US$ 449,346, based on its estimated Ads revenue. ioncologi.com receives approximately 51,848 unique visitors each day. Its web server is located in United States, with IP address 198.71.232.3. According to SiteAdvisor, ioncologi.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$449,346
Daily Ads Revenue US$415
Monthly Ads Revenue US$12,444
Yearly Ads Revenue US$149,322
Daily Unique Visitors 3,457
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
ioncologi.com. A 600 IP: 198.71.232.3
ioncologi.com. NS 3600 NS Record: ns48.domaincontrol.com.
ioncologi.com. NS 3600 NS Record: ns47.domaincontrol.com.
ioncologi.com. MX 3600 MX Record: 20 mx2-us1.ppe-hosted.com.
ioncologi.com. MX 3600 MX Record: 10 mx1-us1.ppe-hosted.com.
ioncologi.com. TXT 3600 TXT Record: v=spf1 a:dispatch-us.ppe-hosted.com include:spf.protection.outlook.com -all
ioncologi.com. TXT 3600 TXT Record: NETORGFT2998056.onmicrosoft.com
HtmlToTextCheckTime:2023-05-08 23:46:04
(352) 559-5100 (352) 559-5100 About Us iOncologi, Inc. iOncologi, Inc. (iOi) is a biotechnology company specializing in immuno-oncology. Launched as a ’spin-out’ cancer immunotherapy firm from the University of Florida, iOi’s founders have developed a novel stem cell therapy that overcomes resistance to immune checkpoint inhibitors in multiple cancers. Novel Immunotherapy Platform Immune checkpoint inhibitors (ICIs), such as anti-CTLA-4 and anti-PD-1 monoclonal antibodies, block inhibitory pathways that prevent the immune system from attacking cancer. These drugs essentially take the brakes off of the body’s own defenses against cancer growth and have dramatically altered the landscape for the treatment of refractory tumors. With several new FDA-approved indications and global market sales projected to exceed $30 billion (USD) in revenue by 2026, ICIs have offered new hope for curative treatment of many advanced malignancies. However, currently over two-thirds of patients treated with
HTTP Headers
HTTP/1.1 301 Moved Permanently
location: https://ioncologi.com/
Vary: Accept-Encoding
Server: DPS/1.12.0
X-SiteId: 2000
Set-Cookie: dps_site_id=2000; path=/
Date: Sat, 30 Oct 2021 21:58:33 GMT
Connection: keep-alive
Keep-Alive: timeout=5

HTTP/2 404 
content-type: text/html;charset=utf-8
content-length: 964
vary: Accept-Encoding
server: DPS/1.12.0
x-siteid: 2000
set-cookie: dps_site_id=2000; path=/; secure
date: Sat, 30 Oct 2021 21:58:33 GMT
ioncologi.com Whois Information
Domain Name: IONCOLOGI.COM
Registry Domain ID: 2093846731_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2021-01-29T17:58:07Z
Creation Date: 2017-01-29T01:53:40Z
Registry Expiry Date: 2023-01-29T01:53:40Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS47.DOMAINCONTROL.COM
Name Server: NS48.DOMAINCONTROL.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-18T08:13:25Z <<<